SCHEMBL11059438

SCHEMBL11059438

COc1ccc(-c2nc(OCCCCCCCC(=O)O)n(-c3ccccc3)c2-c2ccc(OC)cc2)cc1.[NaH]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 2/20 0.52
PPARG P37231 2/20 0.48
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 1/20 0.45
PTGS2 P35354 1/20 0.44
FABP3 P05413 1/20 0.43
FABP4 P15090 1/20 0.43
L3MBTL1 Q9Y468 4/20 0.42
MAPT P10636 1/20 0.42
FFAR1 O14842 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
LMNA P02545 1/20 0.41
NPY1R P25929 1/20 0.41
NPY2R P49146 1/20 0.41
ATM Q13315 1/20 0.41
USP2 O75604 2/20 0.41
CYP1A2 P05177 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10813223 0.99 LTB4R (0.53) LTB4RPPARGALDH1A1MEN1KMT2A
SCHEMBL11056903 0.96 LTB4R (0.52) LTB4RPPARGALDH1A1MEN1KMT2A
SCHEMBL10812727 0.95 LTB4R (0.53) LTB4RPPARGALDH1A1MEN1KMT2A
SCHEMBL10811110 0.91 FAAH (0.49) LTB4RPPARGALDH1A1MEN1KMT2A
SCHEMBL11065721 0.90 LTB4R (0.47) LTB4RFABP3FABP4
SCHEMBL11057073 0.90 LTB4R (0.47) LTB4RFABP3FABP4
Octimibate SCHEMBL9210048 0.90 LTB4R (0.47) LTB4RFABP3FABP4
SCHEMBL11061670 0.90 LTB4R (0.47) LTB4RFABP3FABP4
SCHEMBL11055725 0.90 LTB4R (0.47) LTB4RFABP3FABP4
SCHEMBL11059437 0.90 PPARG (0.45) LTB4RPPARGALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4460598-A Triphenylimidazolyloxyalkanoic acids and their derivatives and a process for the treatment of thromboembolic, inflammatory and/or atheriosclerotic diseases A. NATTERMANN & CIE GMBH (DE) 1984-07-17 US disclosed